N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

Transgenic FAR expression significantly decreases fly survival and increases bacterial load 24-hours post-injection. by Sophia C. Parks (11624976)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

Contact structure can have a significant impact on the population immunity threshold. by Simon Bauer (11378195)

The implementation of the Level III NICU at GPHC was associated with a decrease in the monthly inborn mortality rate as a percent of all live births. by Sara Singh (10774377)

Subjects:

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

PoRVA infection induces significant changes in cellular metabolites in IPEC-J2 cells. by Haixin Liu (7571234)

Subjects:

Image_1_A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD).TIF by Clarissa Elysia Fu (13872713)

“…Poor weight perception increased the risk of adverse events and decreased inclination toward seeking weight loss treatment. …”

Reduction of NPIs by >50% may result increased transmission and significant mortality. by Benjamin U. Hoffman (5470583)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

Estimated short- and long-term cumulative changes in CRC incidence and CRC mortality attributable to screening, diagnosis, and treatment decreases in 2020 and 2021. by Joachim Worthington (8394213)

The outcome timepoints and the mortality level of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Cessation duration and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects: